Evaluating the Impact of Small Versus Large Urethral Stiches (or 'Bites') on Urinary Continence.

NCT ID: NCT07226687

Last Updated: 2025-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

338 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-17

Study Completion Date

2031-05-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the impact of sustainable functional urethral reconstruction (SFUR) on early recovery of urinary continence (UC) after robot-assisted radical prostatectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostatectomy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Prostatectomy Urinary continence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Small Bites

Patients will undergo Robotic-assisted radical prostatectomy (RARP) with vesicourethral anastomosis using small urethral bites, as determined by the surgeon, with goal of being approximately 5-7 mm from the cut edge of the urethra.

Group Type EXPERIMENTAL

Small Urethral Bite Technique

Intervention Type PROCEDURE

The small urethral bite technique involves placing sutures (stitches) that are \~5-7 mm from the edge of the urethra. Each suture penetrates the full thickness of the urethra.

Large Bites

Patients will undergo Robotic-assisted radical prostatectomy (RARP) with vesicourethral anastomosis using large urethral bites, as determined by the surgeon, with goal of being approximately 15-20 mm from the cut edge of the urethra.

Group Type EXPERIMENTAL

Large Urethral Bite Technique

Intervention Type PROCEDURE

The large urethral bite technique involves placing sutures (stitches) that are \~15-20 mm from the edge of the urethra. Each suture penetrates the full thickness of the urethra.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Small Urethral Bite Technique

The small urethral bite technique involves placing sutures (stitches) that are \~5-7 mm from the edge of the urethra. Each suture penetrates the full thickness of the urethra.

Intervention Type PROCEDURE

Large Urethral Bite Technique

The large urethral bite technique involves placing sutures (stitches) that are \~15-20 mm from the edge of the urethra. Each suture penetrates the full thickness of the urethra.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male patients aged 18 years and older.
* Diagnosis of prostate cancer with an indication for robotic-assisted radical prostatectomy (RARP).
* Ability to provide informed consent.

Exclusion Criteria

* History of pelvic radiation therapy
* Prostatectomy performed in the context of salvage therapy (e.g., post-radiation or post-focal therapy)
* Presence of extra-pelvic metastatic disease
* Neurological disorders significantly affecting continence (e.g., severe Parkinson's disease, multiple sclerosis)
* Pre-existing urinary incontinence
* Inability to comply with follow-up protocols
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Chicago

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Scott Eggener

Role: PRINCIPAL_INVESTIGATOR

University of Chicago

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Chicago Medicine Comprehensive Cancer Center

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Clinical Trials Intake

Role: CONTACT

Phone: 855-702-8222

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB25-0202

Identifier Type: -

Identifier Source: org_study_id